Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-Dose Vitamin C Pharmacokinetics in Advanced Solid Tumors
NCT07121036Phase 1Recruiting
- Sponsor
- Zhongnan Hospital of Wuhan University
- Start
- Mar 2025
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of ascorbic acid in solid tumor (3 arms), sponsored by Zhongnan Hospital of Wuhan University. Primary endpoint: Pharmacokinetic characteristics at Day 7. Started Mar 2025; status: recruiting.
02
Drugs
ascorbic acid
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT07121036.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07121036.